Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subjects
Sign Up to like & getrecommendations! Published in 2023 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1212
Abstract: A pharmacokinetic (PK) study and a bioequivalence (BE) study were conducted to investigate the PK characteristics and safety of lubiprostone in healthy Chinese subjects and to evaluate the BE between the test and the reference… read more here.
Keywords: single dose; state; chinese subjects; lubiprostone ... See more keywords